Annual Non Current Assets
$2.46 M
+$525.40 K+27.20%
December 31, 2023
Summary
- As of February 7, 2025, SBFM annual long term assets is $2.46 million, with the most recent change of +$525.40 thousand (+27.20%) on December 31, 2023.
- During the last 3 years, SBFM annual non current assets has risen by +$2.44 million (+12499.49%).
- SBFM annual non current assets is now -100.00% below its all-time high of $125.95 billion, reached on December 1, 2003.
Performance
SBFM Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$4.08 M
+$522.50 K+14.71%
September 30, 2024
Summary
- As of February 7, 2025, SBFM quarterly long term assets is $4.08 million, with the most recent change of +$522.50 thousand (+14.71%) on September 30, 2024.
- Over the past year, SBFM quarterly non current assets has increased by +$1.86 million (+83.94%).
- SBFM quarterly non current assets is now at all-time high.
Performance
SBFM Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
SBFM Non Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +27.2% | +83.9% |
3 y3 years | +10000.0% | +76.3% |
5 y5 years | +5347.7% | +76.3% |
SBFM Non Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | >+9999.0% | at high | >+9999.0% |
5 y | 5-year | at high | >+9999.0% | at high | >+9999.0% |
alltime | all time | -100.0% | -100.0% | at high | -100.0% |
Sunshine Biopharma Non Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $4.08 M(+14.7%) |
Jun 2024 | - | $3.55 M(+15.8%) |
Mar 2024 | - | $3.07 M(+24.9%) |
Dec 2023 | $24.89 M(-8.9%) | $2.46 M(+10.9%) |
Sep 2023 | - | $2.22 M(-4.1%) |
Jun 2023 | - | $2.31 M(+13.1%) |
Mar 2023 | - | $2.04 M(+5.8%) |
Dec 2022 | $27.31 M(+1143.8%) | $1.93 M(>+9900.0%) |
Sep 2022 | - | $3800.00(+137.5%) |
Jun 2022 | - | $1600.00(-60.0%) |
Mar 2022 | - | $4000.00(-43.7%) |
Dec 2021 | $2.20 M(+114.0%) | - |
Dec 2021 | - | $7100.00(-30.4%) |
Sep 2021 | - | $10.20 K(-24.4%) |
Jun 2021 | - | $13.50 K(-18.7%) |
Mar 2021 | - | $16.60 K(-14.9%) |
Dec 2020 | $1.03 M(+1461.5%) | $19.50 K(-14.8%) |
Sep 2020 | - | $22.90 K(-13.3%) |
Jun 2020 | - | $26.40 K(-11.1%) |
Mar 2020 | - | $29.70 K(-8.6%) |
Dec 2019 | $65.70 K(-94.0%) | $32.50 K(-9.2%) |
Sep 2019 | - | $35.80 K(-7.0%) |
Jun 2019 | - | $38.50 K(-96.2%) |
Mar 2019 | - | $1.02 M(+2151.9%) |
Dec 2018 | $1.10 M(+839.8%) | $45.10 K(-95.3%) |
Sep 2018 | - | $953.90 K(-2.0%) |
Jun 2018 | - | $973.60 K(+21.7%) |
Mar 2018 | - | $799.80 K(+470.1%) |
Dec 2017 | $117.20 K(+100.3%) | $140.30 K(+141.5%) |
Sep 2017 | - | $58.10 K(+115.2%) |
Jun 2017 | - | $27.00 K(+400.0%) |
Mar 2017 | - | $5400.00(-8.5%) |
Dec 2016 | $58.50 K(+8.5%) | $5900.00(-99.0%) |
Sep 2016 | - | $576.50 K(-2.5%) |
Jun 2016 | - | $591.50 K(-2.1%) |
Mar 2016 | - | $604.10 K(-2.5%) |
Dec 2015 | $53.90 K | $619.40 K(>+9900.0%) |
Sep 2015 | - | $0.00(0.0%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2015 | - | $0.00(0.0%) |
Mar 2015 | - | $0.00(0.0%) |
Dec 2014 | $143.40 K(+359.6%) | $0.00(0.0%) |
Sep 2014 | - | $0.00(0.0%) |
Jun 2014 | - | $0.00(0.0%) |
Mar 2014 | - | $0.00(0.0%) |
Dec 2013 | $31.20 K(-76.9%) | $0.00(0.0%) |
Sep 2013 | - | $0.00(0.0%) |
Jun 2013 | - | $0.00(0.0%) |
Mar 2013 | - | $0.00(0.0%) |
Dec 2012 | $134.80 K(+26.7%) | $0.00(0.0%) |
Sep 2012 | - | $0.00(0.0%) |
Jun 2012 | - | $0.00(0.0%) |
Mar 2012 | - | $0.00(0.0%) |
Dec 2011 | $106.40 K(-48.7%) | $0.00(0.0%) |
Sep 2011 | - | $0.00(0.0%) |
Jun 2011 | - | $0.00(0.0%) |
Mar 2011 | - | $0.00(0.0%) |
Dec 2010 | $207.60 K(+85.2%) | $0.00(0.0%) |
Sep 2010 | - | $0.00(0.0%) |
Jun 2010 | - | $0.00(0.0%) |
Mar 2010 | - | $0.00(0.0%) |
Dec 2009 | $112.10 K(>+9900.0%) | - |
Oct 2009 | - | $0.00(0.0%) |
Jul 2009 | $600.00(-88.0%) | $0.00(0.0%) |
Apr 2009 | - | $0.00(0.0%) |
Jan 2009 | - | $0.00(0.0%) |
Oct 2008 | - | $0.00(0.0%) |
Jul 2008 | $5000.00(-66.4%) | $0.00(0.0%) |
Apr 2008 | - | $0.00(0.0%) |
Jan 2008 | - | $0.00(0.0%) |
Oct 2007 | - | $0.00 |
Jul 2007 | $14.90 K(-100.0%) | - |
Dec 2003 | $43.61 B(+4.7%) | - |
Dec 2002 | $41.66 B(+36.7%) | - |
Dec 2001 | $30.48 B(-33.6%) | - |
Dec 2000 | $45.93 B(+51.1%) | - |
Dec 1999 | $30.39 B(+34.5%) | - |
Dec 1998 | $22.60 B | - |
FAQ
- What is Sunshine Biopharma annual long term assets?
- What is the all time high annual non current assets for Sunshine Biopharma?
- What is Sunshine Biopharma annual non current assets year-on-year change?
- What is Sunshine Biopharma quarterly long term assets?
- What is the all time high quarterly non current assets for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly non current assets year-on-year change?
What is Sunshine Biopharma annual long term assets?
The current annual non current assets of SBFM is $2.46 M
What is the all time high annual non current assets for Sunshine Biopharma?
Sunshine Biopharma all-time high annual long term assets is $125.95 B
What is Sunshine Biopharma annual non current assets year-on-year change?
Over the past year, SBFM annual long term assets has changed by +$525.40 K (+27.20%)
What is Sunshine Biopharma quarterly long term assets?
The current quarterly non current assets of SBFM is $4.08 M
What is the all time high quarterly non current assets for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly long term assets is $4.08 M
What is Sunshine Biopharma quarterly non current assets year-on-year change?
Over the past year, SBFM quarterly long term assets has changed by +$1.86 M (+83.94%)